NeoGenomics Laboratories

NeoGenomics Laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. We work every day to achieve our common purpose of saving lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency. Our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor FISH testing with the largest menu of technical-only services available; 10-color flow cytometry; IHC supported by an extensive antibody library; and nearly 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. Our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out FISH, flow cytometry, and/or IHC. NeoGenomics’ extremely fast test development cycle means we are highly responsive to therapy development and guideline changes, and test design always involves a balance of convention and innovation. We support clients in many cancer-related market segments, to include: hospital and private pathology laboratories, office-based oncologists, CRO / Biopharmaceutical development organizations, academic institutions / teaching hospitals, and several more.
Fort Myers, US
Size (employees)
850 (est)
NeoGenomics Laboratories was founded in 2002 and is headquartered in Fort Myers, US

NeoGenomics Laboratories Office Locations

NeoGenomics Laboratories has offices in Fort Myers, Nashville, Tampa, Irvine and in 1 other locations
Fort Myers, US (HQ)
9 12701 Commonwealth Dr
Fresno, US
400 30 River Park Pl W
Irvine, US
100 5 Jenner
Tampa, US
228 10002 Princess Palm Ave
Nashville, US
20 618 Grassmere Park

NeoGenomics Laboratories Metrics

NeoGenomics Laboratories Financial Metrics

Revenue (2016)

$244.1 m

Revenue growth (2015-16), %


Gross profit

$110.4 m

Gross profit margin (2016), %


Net income (2016)

($5.7 m)

Market capitalization (21-Mar-2017)

$618.4 m

Closing share price (21-Mar-2017)


Cash (31-Dec-2016)

$12.5 m
NeoGenomics Laboratories's current market capitalization is $618.4 m.
NeoGenomics Laboratories's revenue was reported to be $244.1 m in 2016 which is a 144.6% increase from the previous period.
FY, 2013FY, 2014Y, 2015Y, 2016


$66.5 m$87.1 m$99.8 m$244.1 m

Revenue growth, %


Cost of goods sold

$34.7 m$46.4 m$56 m$133.7 m

Gross profit

$31.7 m$40.7 m$43.8 m$110.4 m

Gross profit Margin, %


Operating expense total

$28.6 m$38.5 m$49.4 m$107.8 m


$3.2 m$2.2 m($5.6 m)$2.6 m

EBIT margin, %


Interest expense

$854 k

Pre tax profit

$1.3 m

Income tax expense

$152 k$157 k($2 m)($1.7 m)

Net Income

$2 m$1.1 m($2.5 m)($5.7 m)
FY, 2013FY, 2014FY, 2015FY, 2016


$4.8 m$33.7 m$23.4 m$12.5 m

Accounts Receivable

$18.7 m$20.5 m$48.9 m$55.5 m


$2.3 m$2.6 m$5.1 m$6.3 m

Current Assets

$27.5 m$58.7 m$99 m$78.8 m


$15.1 m


$2.9 m$146.4 m$147 m

Total Assets

$39.9 m$81.1 m$368 m$337.1 m

Accounts Payable

$4.2 m$6.3 m$12.5 m$16.8 m

Current Liabilities

$14.3 m$14.6 m$40.1 m$38.1 m

Non-Current Liabilities

$89.8 m$112.4 m

Total Liabilities

$129.8 m$150.5 m

Additional Paid-in Capital

$42.2 m$79.8 m$231.4 m$216.1 m

Retained Earnings

($20.5 m)($19.4 m)($21.9 m)($52.5 m)

Total Equity

$21.7 m$60.4 m$209.5 m$163.7 m

Financial Leverage

1.8 x1.3 x1.8 x2.1 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$2 m$1.1 m($2.5 m)($5.7 m)

Depreciation and Amortization

$4.2 m$7.1 m$23.2 m

Accounts Receivable


($229 k)($896 k)($1.1 m)

Accounts Payable

Cash From Operating Activities

$2.2 m$9.5 m$6.4 m$21.5 m

Purchases of PP&E

($2 m)($3.8 m)($2.2 m)($7.5 m)

Cash From Investing Activities

($2 m)($9.6 m)($75.2 m)($6.5 m)

Cash From Financing Activities

$2.8 m$29 m$58.5 m($25.9 m)

Interest Paid

$1.1 m$981 k$911 k$5.4 m

Income Taxes Paid

$17 k$177 k$25 k$290 k

NeoGenomics Laboratories Market Value History

NeoGenomics Laboratories Online Presence

NeoGenomics Laboratories Company Life

You may also be interested in